Ji Yan Biomedical

Jiyan Biomedical is a Shanghai-based biotechnology company specializing in the development of mRNA therapeutics and vaccines. Founded in 2021 by Dr. Wei Zhang, a former Moderna scientist, the company focuses on building an integrated platform for mRNA sequence optimization and proprietary lipid nanoparticle (LNP) delivery systems. Their research and development efforts target high-unmet-need areas including infectious diseases, oncology, and rare genetic disorders. Jiyan Biomedical has secured significant venture capital funding from investors like IDG Capital and GL Ventures to advance its pipeline. The company maintains end-to-end capabilities ranging from early-stage discovery to GMP-compliant manufacturing. By leveraging its deep expertise in RNA biology, Jiyan Biomedical aims to provide innovative and accessible precision medicines to patients globally.